XML 33 R18.htm IDEA: XBRL DOCUMENT v3.24.4
Note 10 - Warrants
 12 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Warrants Disclosure [Text Block]

NOTE 10 – WARRANTS

 

Transactions involving the Company equity-classified warrants for the fiscal years ended September 30, 2024 and 2023 are summarized as follows:

 

  

Number of shares

  

Weighted-average exercise price

  

Weighted-average remaining contractual term (in years)

  

Aggregate intrinsic value (in thousands)

 

Outstanding at September 30, 2022

  13,204  $210.45   2.30  $- 

Granted

  40,500   2.52   -     

Exercised

  -   -         

Forfeited

  (3,395)  242.55         

Outstanding at September 30, 2023

  50,309   37.75   2.30   - 

Granted

  -   -   -     

Exercised

  -   -         

Forfeited

  (1,352)  337.50         

Outstanding at September 30, 2024

  48,957   337.50   4.07   - 
                 

Exercisable at September 30, 2024

  48,957  $29.48   -  $- 

 

The following table summarizes outstanding common stock purchase warrants as of September 30, 2024:

 

  

Number of shares

  

Weighted-average exercise price

 

Expiration

Exercisable at $176.06 per share

  1,079   176.06 

October 2024

Exercisable at $56.25 per share

  822   56.25 

January 2025

Exercisable at $168.30 per share

  3,357   168.30 

December 2025

Exercisable at $168.75 per share

  3,199   168.75 

June 2026

Exercisable at $2.52 per share

  40,500   2.52 

April 2028

   48,957  $37.75